Initial Drug Listing - RoyceDerm Seborrheic Dermatitis & Psoriasis Shampoo- 169
- Manufacturer
- RoyceDerm LLC
- Effective date
- 2026-03-16
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 01:53:40
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Salicylic Acid USP
OTC - PURPOSE SECTION
Seborrheic dermatitis and psoriasis
DOSAGE & ADMINISTRATION SECTION
Relieves and helps prevent recurrence of scalp: itching, flaking, scaling, redness, and irritation associated with psoriasis and seborrheic dermatitis.
WARNINGS SECTION
For external use only.
OTC - ASK DOCTOR SECTION
condition covers a large area of the body.
OTC - WHEN USING SECTION
Avoid contact with eyes. If contact occurs, rinse the eyes thoroughly with water.
OTC - STOP USE SECTION
Stop use and ask a doctor if
condition worsens or does not improve after regular use as directed
OTC - PREGNANCY OR BREAST FEEDING SECTION
Ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
In case of accidental ingestion, seek medicaladvice immediately or contact a Poison Control Center right away. (1-800-222-1222)
INDICATIONS & USAGE SECTION
- Apply shampoo & massage into the scalp.
- Leave in hair for 3-5 minutes to allow maximum absorption.
- Rinse and repeat as needed.
- Use daily for best results.
- Do not use it on children under 12 years of age unless directed by a doctor.
OTHER SAFETY INFORMATION
Store at room temperature and out of direct sunlight
INACTIVE INGREDIENT SECTION
Water, Disodium EDTA, Citric acid, SodiumCitrate, Plantapon L61l, ChembetaineCAD, Lamesoft PO65, Glycerin, Zemea Propanediol, Chlorhexidine gluconate,Sodium Benzoate, Dex Panthenol,Polyquaternium-44, Calendula extract,Chamomile extract
OTC - QUESTIONS SECTION
Visit
www.roycederm.com
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
Product Linked Resources#
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| QR code link | QR Code | package.jpg |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 6c13b22c-b3ba-4127-b768-0132dd5ab0d1 | Product name | 1 | 20230829 |
| bb6d6c68-649d-4e6d-a1f6-603d969c8f68 | Product name | 1 | 20160303 |
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 85424-020-01 | RoyceDerm Seborrheic Dermatitis and Psoriasis Shampoo. | 250 g in 1 CARTON | SHAMPOO | 250 | 1 |
Products#
Every source-derived product name is available through these pages.
- RoyceDerm Seborrheic Dermatitis and Psoriasis Shampoo.
- Salicylic Acid 3%
- GLYCERIN
- PANTHENOL
- CITRIC ACID
- GLYCERYL OLEATE
- COCAMIDOPROPYL BETAINE
- LAURDIMONIUMHYDROXYPROPYL COCOGLUCOSIDES CHLORIDE
- WATER
- SALICYLIC ACID
- EDETATE DISODIUM
- SODIUM CITRATE
- PROPANEDIOL
- CHLORHEXIDINE GLUCONATE
- CALCIUM DISODIUM EDTA
- SODIUM LAURETH SULFATE
- SODIUM BENZOATE
- CALENDULA OFFICINALIS FLOWER
- PROPYLENE GLYCOL
- POLYQUATERNIUM-44 (200000 MW)
- MATRICARIA CHAMOMILLA FLOWERING TOP
- LAURYL GLUCOSIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 85424-020 | 85424-020-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| RoyceDerm Seborrheic Dermatitis and Psoriasis Shampoo. | SALICYLIC ACID 3% | RoyceDerm LLC | 4d2f6e29-5d75-6982-e063-6294a90ada8d | 2026-03-16 | Warnings | 85424-020-01 85424-020 85424002001 4d2f6e29-5d76-6982-e063-6294a90ada8d 4d2f6e29-5d75-6982-e063-6294a90ada8d |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
